Indian markets see renewed investor interest in pharma, speciality chemicals, and exchange-traded services, with recent earnings showing mixed signals. Pharma valuations are attractive, with Sun Pharma and MNCs like GSK and Pfizer showing promise. Speciality chemicals require patience, while BSE’s performance is linked to market sentiment and NSE’s upcoming listing.
From LLMs to superintelligence, Vijay Kedia decodes AI stack for investors
Investor Vijay Kedia outlines AI’s evolution in investing, from LLMs offering insights to agentic and multi-agent systems executing trades, culminating in AGI and superintelligence capable
April 10, 2026